These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 3492311)

  • 1. Induction of alkoxyresorufin O-dealkylases, epoxide hydrolase, and liver weight gain: correlation with liver tumor-promoting potential in a series of barbiturates.
    Nims RW; Devor DE; Henneman JR; Lubet RA
    Carcinogenesis; 1987 Jan; 8(1):67-71. PubMed ID: 3492311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A markedly diminished pleiotropic response to phenobarbital and structurally-related xenobiotics in Zucker rats in comparison with F344/NCr or DA rats.
    Lubet RA; Nims RW; Dragnev KH; Jones CR; Diwan BA; Devor DE; Ward JM; Miller MS; Rice JM
    Biochem Pharmacol; 1992 Mar; 43(5):1079-87. PubMed ID: 1554380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P-450 enzyme induction by 5-ethyl-5-phenylhydantoin and 5,5-diethylhydantoin, analogues of barbiturate tumor promoters phenobarbital and barbital, and promotion of liver and thyroid carcinogenesis initiated by N-nitrosodiethylamine in rats.
    Diwan BA; Rice JM; Nims RW; Lubet RA; Hu H; Ward JM
    Cancer Res; 1988 May; 48(9):2492-7. PubMed ID: 3356011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pleiotropic response to phenobarbital-type enzyme inducers in the F344/NCr rat. Effects of chemicals of varied structure.
    Lubet RA; Dragnev KH; Chauhan DP; Nims RW; Diwan BA; Ward JM; Jones CR; Rice JM; Miller MS
    Biochem Pharmacol; 1992 Mar; 43(5):1067-78. PubMed ID: 1372805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of hepatic cytochrome P-450 mediated alkoxyresorufin O-dealkylase activities in different species by prototype P-450 inducers.
    Lubet RA; Syi JL; Nelson JO; Nims RW
    Chem Biol Interact; 1990; 75(3):325-39. PubMed ID: 2379261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative tumor-promoting activities of phenobarbital, amobarbital, barbital sodium, and barbituric acid on livers and other organs of male F344/NCr rats following initiation with N-nitrosodiethylamine.
    Diwan BA; Rice JM; Ohshima M; Ward JM; Dove LF
    J Natl Cancer Inst; 1985 Feb; 74(2):509-16. PubMed ID: 3856057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of hepatocarcinogenesis and induction of specific cytochrome P450-dependent monooxygenase activities by the barbiturates allobarbital, aprobarbital, pentobarbital, secobarbital and 5-phenyl- and 5-ethylbarbituric acids.
    Rice JM; Diwan BA; Hu H; Ward JM; Nims RW; Lubet RA
    Carcinogenesis; 1994 Feb; 15(2):395-402. PubMed ID: 8313534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promotion by sodium barbital of renal cortical and transitional cell tumors, but not intestinal tumors, in F344 rats given methyl(acetoxymethyl)nitrosamine, and lack of effect of phenobarbital, amobarbital, or barbituric acid on development of either renal or intestinal tumors.
    Diwan BA; Ohshima M; Rice JM
    Carcinogenesis; 1989 Jan; 10(1):183-8. PubMed ID: 2910521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-response relationships for the induction of P450 2B by 1,4-bis[2-(3,5-dichloropyridyloxy)]benzne (TCPOBOP) in rat and cultured rat hepatocytes.
    Nims RW; Sinclair PR; Sinclair JF; Dragnev KH; Jones CR; Mellini DW; Thomas PE; Lubet RA
    Xenobiotica; 1993 Dec; 23(12):1411-26. PubMed ID: 7510916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colocalized alterations in connexin32 and cytochrome P450IIB1/2 by phenobarbital and related liver tumor promoters.
    Neveu MJ; Babcock KL; Hertzberg EL; Paul DL; Nicholson BJ; Pitot HC
    Cancer Res; 1994 Jun; 54(12):3145-52. PubMed ID: 8205533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor promoting activities of ethylphenylacetylurea and diethylacetylurea, the ring hydrolysis products of barbiturate tumor promoters phenobarbital and barbital, in rat liver and kidney initiated by N-nitrosodiethylamine.
    Diwan BA; Nims RW; Ward JM; Hu H; Lubet RA; Rice JM
    Carcinogenesis; 1989 Jan; 10(1):189-94. PubMed ID: 2910522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic cytochrome P450 2B-type induction by ethyl/phenyl-substituted congeners of phenobarbital in the rat.
    Nims RW; Syi JL; Wink DA; Nelson VC; Thomas PE; Jones CR; Diwan BA; Keefer LK; Rice JM; Lubet RA
    Chem Res Toxicol; 1993; 6(2):180-7. PubMed ID: 8477009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative pharmacodynamics of hepatic cytochrome P450 2B induction by 5,5-diphenyl- and 5,5-diethyl-substituted barbiturates and hydantoins in the male F344/NCr rat.
    Nims RW; McClain RM; Manchand PS; Belica PS; Thomas PE; Mellini DW; Utermahlen WE; Lubet RA
    J Pharmacol Exp Ther; 1994 Jul; 270(1):348-55. PubMed ID: 8035330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of barbiturates on the hepatic cytochrome P-450 dependent enzyme system and biliary excretion of exogenous organic anions in rats.
    Fischer E; Gregus Z; Varga F
    Digestion; 1980; 20(2):115-20. PubMed ID: 6767638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose-response relationships for cytochrome P450 induction by phenobarbital in the cotton rat (Sigmodon hispidus).
    Jones CR; Lubet RA; Henneman JR; Nims RW
    Comp Biochem Physiol C Pharmacol Toxicol Endocrinol; 1998 Nov; 121(1-3):197-203. PubMed ID: 9972461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the oxazolidinedione anticonvulsants trimethadione and dimethadione and the barbiturate homolog 5,5-dimethylbarbituric acid on N-nitrosodiethylamine-initiated renal and hepatic carcinogenesis in the F344/NCr rat.
    Diwan BA; Nims RW; Henneman JR; Ward JM; Lubet RA; Rice JM
    Arch Toxicol; 1992; 66(6):413-22. PubMed ID: 1444806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Barbiturate-induced choleresis: possible independence from microsomal enzyme induction.
    Capron JP; Dumont M; Feldmann G; Erlinger S
    Digestion; 1977; 15(6):556-65. PubMed ID: 913919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methoxyresorufin and benzyloxyresorufin: substrates preferentially metabolized by cytochromes P4501A2 and 2B, respectively, in the rat and mouse.
    Nerurkar PV; Park SS; Thomas PE; Nims RW; Lubet RA
    Biochem Pharmacol; 1993 Sep; 46(5):933-43. PubMed ID: 8373445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EGF receptors of hepatocytes from rats treated with phenobarbital are sensitized to down-regulation by phenobarbital in culture.
    Dalton SR; Jirtle RL; Meyer SA
    Toxicol Appl Pharmacol; 2000 Jun; 165(2):115-26. PubMed ID: 10828207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Susceptibility to phenobarbital promotion of hepatotumorigenesis: correlation with differential expression and induction of hepatic drug metabolizing enzymes in heavy and light male (C3H x VY) F1 hybrid mice.
    Wolff GL; Leakey JE; Bazare JJ; Harmon JR; Webb PJ; Law MG
    Carcinogenesis; 1991 May; 12(5):911-5. PubMed ID: 1674234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.